Hence, while α1AT administration reduced B. pertussis-induced leukocytosis but failed to protect against B. pertussis-induced airway pathology in the study presented here, we cannot rule out the potential for higher doses of α1AT to ameliorate this phenotype. This evidence concerns the gene SERPINA1 and Increased total leukocyte count.